43
The Use of Lay Patient Navigators to Improve Quality of Care and Accrual to Clinical Trials for Radiation Oncology Patients who are Minorities or of Low Socioeconomic Status ASTRO Philadelphia, Pa. November,2006 Principal Investigator Michael L. Steinberg, MD, FACR Co-Principal Investigators David Huang, MD David Khan, MD Allen Fremont, MD, PhD Nell Forge, PhD Oscar Streeter, MD Mack Roach, MD

The Use of Lay Patient Navigators to Improve Quality of Care and Accrual to Clinical Trials for Radiation Oncology Patients who are Minorities or of Low

Embed Size (px)

Citation preview

  • The Use of Lay Patient Navigators to Improve Quality of Care and Accrual to Clinical Trials for Radiation Oncology Patients who are Minorities or of Low Socioeconomic Status

    ASTROPhiladelphia, Pa.November,2006Principal InvestigatorMichael L. Steinberg, MD, FACRCo-Principal InvestigatorsDavid Huang, MDDavid Khan, MDAllen Fremont, MD, PhDNell Forge, PhDOscar Streeter, MDMack Roach, MD

  • Profound advances in medical science have contributed to:

    Increased longevity Improved quality of life for many Americans. H.Freeman

  • Despite these advances, some Americans have not fully benefited from this progress - particularly the poor and underserved - as evidenced by their higher cancer incidence and lower survival. H Freeman

  • Causes of Health DisparitiesFreeman, Adapted from Cancer Epidemiology Biomarkers & Prevention, April 2003PreventionTreatmentPost Treatment/ Quality of LifeSurvival and MortalitySocial InjusticeEarly DetectionDiagnosis/ IncidenceCulturePoverty/ Low Economic Status

  • Cancer Disparities Research Partnerships ProgramPartnerPatient NavigatorTelesynergyAwardeePt. NavigatorNCI Cancer Center PartnerPatient

  • Turning the Funding Paradigm Upside Down

    Traditional

    Regional Comprehensive Cancer Centers

    Local Urban/Rural Hospitals Serving Target Populations

    All Comprehensive Cancer Centers

    Urban/Rural HospitalsServing Target Populations

    CDRP

    Telemedicine LinkagesMentor Relationship

  • Cancer Disparities Research Partnership Program (CDRP)5-year grant The program components:Radiation oncology clinical trials infrastructureResearch/Mentoring PartnershipsTelecommunication TELESYNERGY

  • U.S. MapU.S. MAP

  • ULAACUrban Latino African American CancerHealth Disparities Project

    Centinela Freeman Regional Medical Center

  • ULAAC OBJECTIVESEstablished the infrastructure to conduct cancer clinical trials Developed a lay patient navigator program primary goals To decrease barriers to receiving cancer care To examine the possibility of increasing voluntary accrual to clinical trials though the function of the lay navigator

  • CFHS Service Area

  • Centinela Freeman HealthSystem Service Area

    Centinela Freeman Marina Campus

    Centinela Freeman Daniel Freeman Campus

    Centinela Freeman Centinela Campus

  • Our Patients

  • Our PartnersCentinela Freeman

    USC

    UCSF

    RAND

  • Initial Navigator Concepts Cancer care is a complex and multi-factorial series of interactions with the healthcare system Patient navigators (culturally appropriate personal patient advocates) can facilitate patients through the care process. The concept of a patient navigator and the corresponding literature shows wide variance in definitions and implementation

  • INITIAL CONSIDERATIONS Lay Navigator program best fit our needs Diversity of ethnicity and language in service area Perceived cost

    All patients are offered navigation and continue to receive navigation whether they qualify for or participate in clinical trials

  • INFRASTRUCTUREOffices/Community Center

    Staff:Debbie Karaman, MPH, Community Health EducatorErika Cobb, Administrative AssistantHershel Knapp, PhD, MSWMagdalena Serrano, USC MSW InternNicole Harada, Clinical Trials CoordinatorSusan Richardson, RN, Oncology NurseKeith Andre, MA, Project Administrator

    Community Liaison:MABCAB

  • Abnormal resultsDiagnosisTreatmentConclude NavigationCancer Disparities Research Partnership (CDRP)Patient Navigation Model OutreachPatient NavigationRehabilitationAbnormal ResultsDiagnosisTreatmentAbnormal FindingResolutionConclude NavigationFreeman, et.al., Cancer Practice, 1995.Cancer Diagnosis

  • LAY NAVIGATOR ROLEThe navigators primary function is guiding cancer patients through the health care systemAssisting with access issuesDeveloping relationships with service providers Tracking interventions and outcomes

  • RECRUITING AND SCREENING PROSPECTIVE LAY NAVIGATORSCommunity Health Educator Networking:Phone E-mail Community Advisory Board Screening PhoneOrientation Session Prior to Training Motivations

  • TRAINING COURSE The navigator 6 hour training course over 3 days emphasizes:Investigating and implementing resources for patients in a timely fashionOffering compassionate andnon-judgmental communicationactive listening skillsCompleting appropriate records of all interactions on behalf of patientEmpowering patients toself-advocate in the healthcare realm

  • Training Program

    Chart7

    17

    14

    8

    9

    Sheet1

    African AmericansCaucasiansLatinosAsiansOther

    507431

    Percentage accepted

    LatinosAsiansAfrican AmericansCaucasiansOther

    83%67%64%58%50%

    Sheet1

    Sheet2

    TransportationPsychosocialFinancialFear of CancerCaregiverLanguage

    6533191187

    Group 1Group 2Group 3Group 4

    10548

    Sheet2

    Sheet3

    Not interestedSelf sufficientStrong family supportUnable to contactPrevious cancerMedical background

    36147521

    Group 1Group 2Group 3Group 4

    171489

  • Active Navigators

    Chart5

    10

    5

    4

    8

    Sheet1

    African AmericansCaucasiansLatinosAsiansOther

    507431

    Percentage accepted

    LatinosAsiansAfrican AmericansCaucasiansOther

    83%67%64%58%50%

    Sheet1

    Sheet2

    TransportationPsychosocialFinancialFear of CancerCaregiverLanguage

    6533191187

    Group 1Group 2Group 3Group 4

    10548

    Sheet2

    Sheet3

  • Ethnicity of Active Navigators

    Chart8

    21

    4

    1

    1

    Sheet1

    African AmericansCaucasiansLatinosAsiansOther

    507431

    Percentage accepted

    LatinosAsiansAfrican AmericansCaucasiansOther

    83%67%64%58%50%

    Sheet1

    Sheet2

    TransportationPsychosocialFinancialFear of CancerCaregiverLanguage

    6533191187

    Group 1Group 2Group 3Group 4

    10548

    Sheet2

    Sheet3

    Not interestedSelf sufficientStrong family supportUnable to contactPrevious cancerMedical background

    36147521

    Group 1Group 2Group 3Group 4

    171489

    African AmericansLatinosNative AmericanPacific Islander

    21411

  • Navigators Who Are CancerSurvivors

    Chart9

    12

    2

    1

    1

    1

    Sheet1

    African AmericansCaucasiansLatinosAsiansOther

    507431

    Percentage accepted

    LatinosAsiansAfrican AmericansCaucasiansOther

    83%67%64%58%50%

    Sheet1

    Sheet2

    TransportationPsychosocialFinancialFear of CancerCaregiverLanguage

    6533191187

    Group 1Group 2Group 3Group 4

    10548

    Sheet2

    Sheet3

    Not interestedSelf sufficientStrong family supportUnable to contactPrevious cancerMedical background

    36147521

    BreastProstateEsophagealColonLung

    122111

    Group 1Group 2Group 3Group 4

    171489

    African AmericansLatinosNative AmericanPacific Islander

    21411

  • Patient Navigation Data67% accepted navigation

    Chart4

    261

    172

    89

    Sheet1

    ApproachedAcceptedDeclined

    26117289

    Sheet1

    Sheet2

    Sheet3

  • Ethnicity of Patients ApproachedPercentage Breakdown: 71% African Americans, 13% Latinos, 11% Caucasians, 4% Asians, 1% Other

    Chart2

    185

    34

    29

    10

    3

    Sheet1

    African AmericansLatinosCaucasiansAsiansOthers

    1853429103

    Sheet1

    Sheet2

    Sheet3

  • Ethnicity of Patients Accepting Navigation

    Chart2

    0.71

    0.7

    0.67

    0.55

    0.33

    Sheet1

    24/347/10124/18516/291/3

    LatinosAsiansAfrican AmericansCaucasiansOthers

    71%70%67%55%33%

    Sheet1

    Sheet2

    Sheet3

  • Reasons for Declining Navigation

    Chart6

    57

    14

    10

    5

    2

    1

    Sheet1

    African AmericansCaucasiansLatinosAsiansOther

    507431

    Percentage accepted

    LatinosAsiansAfrican AmericansCaucasiansOther

    83%67%64%58%50%

    Sheet1

    Sheet2

    TransportationPsychosocialFinancialFear of CancerCaregiverLanguage

    6533191187

    Group 1Group 2Group 3Group 4

    10548

    Sheet2

    Sheet3

    Not interestedSelf sufficientStrong family supportUnable to contactPrevious cancerMedical background

    571410521

  • ASSESSMENT OF EFFECTIVENESS AND QUALITY ASSURANCENavigators and patients queried multiple times and in various ways during the navigation processAssessments used to modify training and navigation processAssess effectiveness of various components of the program

  • ASSESSMENT OF EFFECTIVENESS ADDRESSING BARRIERS

    Identification of patient specific barriers to careChart and navigation records are audited to determine time to solution of barrier The deficiencies receive follow up by staff and are identified and tracked in a database

  • Barriers to Care: Chart Audit

  • 6 Most Common Barriers

    Chart4

    65

    33

    19

    11

    8

    7

    Sheet1

    African AmericansCaucasiansLatinosAsiansOther

    507431

    Percentage accepted

    LatinosAsiansAfrican AmericansCaucasiansOther

    83%67%64%58%50%

    Sheet1

    Sheet2

    TransportationPsychosocialFinancialFear of CancerCaregiverLanguage

    6533191187

    Sheet2

    Sheet3

  • Results of Clinical Trials Accrual 7 Trials Open5 NCI/RTOG Sponsored Trials1 NCIC Sponsored Trial1 Multi-institution device Trial

  • Trial Enrollment

    Chart2

    8

    6

    4

    3

    1

    1

    1

    Sheet1

    African AmericansLatinosCaucasiansAsians

    16331

    MenWomen

    158

    P4RTOG 0315RTOG 0321MammoSite DCISRTOG 0413RTOG 9804RTOG 0232

    8643111

    Sheet1

    Sheet2

    Sheet3

  • Accrual to Trial by Ethnicity

    Chart3

    16

    3

    3

    1

    Sheet1

    African AmericansLatinosCaucasiansAsians

    16331

    MenWomen

    158

    P4RTOG 0315RTOG 321MammoSite DCISRTOG 0413RTOG 9804RTOG 0232

    7633211

    Sheet1

    Sheet2

    Sheet3

  • Clinical Trials Participation(14 month time period)

    Chart2

    24

    17

    16

    Sheet1

    EligibleScreenedEnrolled

    241716

    Sheet1

    Sheet2

    Sheet3

  • Reasons for Non Accrual to Clinical Trial

    Chart3

    3

    1

    2

    1

    1

    Sheet1

    Preferred Traditional TxScreened/IneligibleDid not feel it was necessaryFelt overwhelmedLack of Support

    31211

    Sheet1

    Sheet2

    Sheet3

  • Clinical Trial Accrual/Navigation

  • Cancer Post-Treatment Survey

    Are there quantitative differences between patients who received navigation versus those who did not in various QOL domains?Are there patient perceived quality of care differences in the two groups?

  • Cancer Post-Treatment SurveySource:RTOG A-5 Demographic SurveyFACIT and Model QuestionsDomains EvaluatedSpiritualSocial/Family Physical Emotional Functional Patient Centered QuestionsRelationship Based Questions

  • CONCLUSIONOngoing Evaluation Will Provide Practical Information Regarding Elimination of barriers to care Quality assessment of lay navigation Effects of navigation on accrual to clinical trials

  • Still Too Separate, Not Yet Equal A. Epstein Most Existing Information On Disparity Focuses OnAbility To Afford CareKnowledge, Beliefs, PreferencesDoctor/Patient RelationshipBach Suggests That Structural Features Of The Delivery System Contribute To Disparity in Quality

  • Still Too Separate, Not Yet Equal A. Epstein Describing And Explaining Disparities Is Much Easier Than Devising Strategies To Reduce Disparities Researchers Should Shift Focus To Developing Infrastructure and Improving Policies That Will Reduce Disparities

    DISEASE EXISTS IN THE CONTEXT OF HUMAN CIRCUMSTANCES WHICH AFFECT THE CARE PROCESS. THESE CIRCUMSTANCES ARE DETERMINANTS CAUSES OF DISPARITY TO ADDRESS THIS PROBLEM THE CDRP WAS FORMED INSTEAD OF AWARDING GRANT TO CCC, GRANTS WERE GIVEN TO COMMUNITY HOSPTIALS SERVING THE TARGET COMMUNITY THE NOTION OF THAT NAVIGATION WOULD BE USEFUL IS BASED ON;1. CANCER CARE IS COMPLEX AND MULTIFACTORIAL2 NAVIGATORS CAN FACILITATE PATIENT THRU THE PROCESS. THERE ARE A VARIETY OF MODELS INCLUDED GUIDING PT THRU SYSTEM, ADDRESS ACCESS ISSUES, DEVELOP RELATIONSHIPS WITH SERVICE PROVIDERS, TRACK INTERVENTIONSUSING COMMUNITY RESOURCES CHS NETWORKS TO GATHER PROSPECTIVE NAVIGATORS THE SCREENS AS TO MOTIVATION AND EXPECTATION INCLUDED TRAINING IN COMMUNITY RESOURCES, ACTIVE LISTENTING SKILLS, MEDICAL RECORD KEEPING, PATIENT SELF ADVOCACY WE HAVE HAD 4 TRAINING PROGRAMS OF THE 48 WHO TOOK THE COURSE 27 WENT ON TO NAVIGATE PATIENTS THE ETHNICITY OF OUR NAVIGATORS MIMICS OUR PATIENT POPULATION 17 NAVIGATORS ARE CANCER SURVIVORS OF THE 261 APPROACHED 172 ACCEPTED NAVIGATION LATINOS ASIANS AND AFRICAN AMERICANS ACCEPTED NAVIGATION AT SIMILAR LEVEL MOST COMMON REASON WAS LACK OF INTEREST VARIOUS QUALITY ASSESSMENT TOOLS WERE USED TO ASSES EFFECTIVNESS OF THE PROGRAM

    INCLUDING ASSESMENT OF BARRIERS AND EFFECTIVENESS OF TIMELYNESS OF SOLUTIONS SPREAD SHEETS ADDRESSING BARRIERS ARE REVIEWED WEEKLY FOR EFFICACY OF NAVIGATION PROCESS MOST COMMON BARRIER IN OUR COMMIUNTY IS TRANSPORTATIONTHE RESULT OF CLINCAL TRIAL ACCURAL IN THE FIRST 14 MO WITH TOTAL OF 7 TRIALS OPEN ARE AS FOLLOWSTOTAL OF 23 PTS ENROLLED INTO TRAIL, ONE INTO 2 TRIALS FOR A TOTAL ENROLLEMENT OF 24 ACCRUAL BY ETHNICTY WAS SIMILAR TO PATIENT MIX THERE WERE 24 WHO WERE DEEMED ELEGIBLE FOR THE CLINICAL TRIAL (NON GENOMIC) 17 ACCPETED SCREENING : 71% 16 OR 66% WENT ON TRIAL7 DECLINED ; 1 WAS NOT ELIGIBLE UPON SCREENINGOTHER REASON FOR REFUSING ARE NOTED We are in the process of analyzing our intake data in these patients determine potential benefits of navigation in the processSINCE THERE ARE 2 GROUPS OF PTS NAVIGATED AND NON NAVIGATED WE DEVELOPED ..